Skip to main content
Beth Karlan, MD, Obstetrics & Gynecology, Los Angeles, CA, Ronald Reagan UCLA Medical Center

BethKarlanMD

Obstetrics & Gynecology Los Angeles, CA

Gynecologic Oncology

David Geffen School of Medicine at UCLA Vice Chair, Women's Health Research Director, Cancer Population Genetics

Dr. Karlan is on Doximity

As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.

  • Connect with other colleagues in the same hospital or clinic
  • Search all U.S. specialist profiles and refer a patient
  • Read the latest clinical news and earn CME/CEU credits

See Dr. Karlan's full profile

Already have an account?

  • Office

    UCLA Medical Center
    100 UCLA Medical Plaza, Suite 383
    Los Angeles, CA 90095
    Phone+1 310-794-7274
    Fax+1 310-794-7274
  • Is this information wrong?

Summary

  • Beth Y. Karlan, M.D. is Professor and Vice Chair of Women’s Health Research in the Department of Obstetrics and Gynecology at the David Geffen School of Medicine, University of California Los Angeles (UCLA). She is also Director of Cancer Population Genetics at the Jonsson Comprehensive Cancer Center at UCLA. Dr. Karlan’s research focuses on ovarian and other women’s cancers as well as inherited cancer susceptibility. She has authored over 350 research publications and is an American Cancer Society Clinical Research Professor. Dr. Karlan is Editor-in-Chief of the scientific journals Gynecologic Oncology and Gynecologic Oncology Reports, and is a Fellow of the American Society of Clinical Oncology. In 2012, Dr. Karlan was appointed by the White House to serve on the National Cancer Advisory Board, and in 2015 she was elected to membership in the National Academy of Medicine.

Education & Training

  • Yale-New Haven Medical Center
    Yale-New Haven Medical CenterResidency, Obstetrics and Gynecology, 1982 - 1986
  • Harvard Medical School
    Harvard Medical SchoolClass of 1982
  • Harvard-Radcliffe College
    Harvard-Radcliffe CollegeB.A., Biochemical Sciences, Magna Cum Laude, 1978

Certifications & Licensure

  • CA State Medical License
    CA State Medical License 1986 - 2026
  • American Board of Obstetrics and Gynecology Obstetrics & Gynecology
  • American Board of Obstetrics and Gynecology Gynecologic Oncology

Awards, Honors, & Recognition

  • Lifetime Achievement Award International Gynecologic Cancer Society, 2021
  • Giants of Cancer Care, Gynecologic Malignancies OncLive, 2019
  • Director's Service Award National Cancer Institute, 2018
  • Join now to see all

Clinical Trials

Publications & Presentations

Journal Articles

  • Association of p16 Expression with Prognosis Varies Across Ovarian Carcinoma Histotypes: An Ovarian Tumor Tissue Analysis Consortium Study  
    Robert P Edwards, Beth Y Karlan, Andrew Berchuck, The Journal of Pathology: Clinical Research
  • Variants in Genes Encoding Small GTPases and Association with Epithelial Ovarian Cancer Susceptibility  
    Julie M Cunningham, Robert P Edwards, Elizabeth M Poole, Tanja Pejovic, Karen Lu, Kunle Odunsi, Beth Y Karlan, Christine S Walsh, Douglas A Levine, Andrew Berchuck, Da..., PLoS One
  • Functional Mechanisms Underlying Pleiotropic Risk Alleles at the 19p13.1 Breast–Ovarian Cancer Susceptibility Locus  
    Susan M Domchek, Beth Y Karlan, Katherine L Nathanson, Kenneth Offit, Banu K Arun, Andrew Berchuck, Patricia A Ganz, Douglas A Levine, Nature
  • Join now to see all

Books/Book Chapters

  • Join now to see all

Abstracts/Posters

  • Morbidity of triplemodality therapy in the management of early stage cervical cancer.
    Park SK, Axtell AE, Hakimian B, Li A, Leuchter R, Karlan B, Rimel BJ, Walsh C, Cass I, Western Association of Gynecologic Oncologists Meeting, Truckee, CA, 6/25/2014
  • A KRAS hotspot mutation correlates with MLH1 methylation in endometrial carcinomas with microsatellite instability: A potential triage tool for Lynch Syndrome evaluation.
    Cohen J, Wiedemeyer R, Karlan B, Walsh C, Society of Gynecologic Oncology 45th Annual Meeting on Women's Cancer, Tampa, FL, 3/22/2014
  • Genomic characterization of grade 3 endometrial carcinoma.
    Cohen J, Goodman M, Karlan B and Walsh C, Society of Gynecologic Oncology 45th Annual Meeting on Women's Cancer, Tampa, FL, 3/22/2014
  • Join now to see all

Lectures

  • Occult and subsequent gynecologic cancers following risk-reducing salpingo-oophorectomies (RRSO) in BRCA mutation carriers. 
    Truckee, CA - 6/25/2014
  • The prognostic significance of ADAM metallopeptidase domain 12 in advanced stage serous ovarian cancer. 
    Truckee, CA - 6/25/2014
  • "The Mechanics of Writing and Publishing Great Papers: Perspecitive from the Editor-in-Chief of Gynecologic Oncology", Inaugural Lecturer 
    University of Alabama, Birmingham, AL - 11/15/2013
  • Join now to see all

Other

  • "Interview for Lifescript.com" 
    Beth Young Karlan, MD
    1/1/2013
  • "Interview for Studio 11" 
    Beth Young Karlan, MD
    1/1/2013
  • CA-125: To monitor or not to monitor? 
    Rustin G, Karlan BY and Markman M
    http://www.medscape.com
    3/8/2012
  • Join now to see all

Authored Content

  • Disappointing but Important: Cervical Cancer OUTBACK Trial’s Negative ResultsJune 2021

Press Mentions

  • Researchers Finds How the Ovarian Cancer Can Develop in Women
    Researchers Finds How the Ovarian Cancer Can Develop in WomenJanuary 3rd, 2022
  • Health News | Research Explains How Ovarian Cancer Begins in High-Risk Women
    Health News | Research Explains How Ovarian Cancer Begins in High-Risk WomenJanuary 2nd, 2022
  • Researchers Create Organoids That Model BRCA-Positive Ovarian Cancer
    Researchers Create Organoids That Model BRCA-Positive Ovarian CancerDecember 29th, 2021
  • Join now to see all

Professional Memberships

Hospital Affiliations